BR112013031813A2 - composição para aplicação tópica - Google Patents

composição para aplicação tópica

Info

Publication number
BR112013031813A2
BR112013031813A2 BR112013031813A BR112013031813A BR112013031813A2 BR 112013031813 A2 BR112013031813 A2 BR 112013031813A2 BR 112013031813 A BR112013031813 A BR 112013031813A BR 112013031813 A BR112013031813 A BR 112013031813A BR 112013031813 A2 BR112013031813 A2 BR 112013031813A2
Authority
BR
Brazil
Prior art keywords
composition
topical application
topical
application
Prior art date
Application number
BR112013031813A
Other languages
English (en)
Inventor
Haim Bar-Simantov
Ofer Toledano
Original Assignee
Sol Gel Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sol Gel Technologies Ltd filed Critical Sol Gel Technologies Ltd
Publication of BR112013031813A2 publication Critical patent/BR112013031813A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203Retinoic acids ; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/327Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/501Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
BR112013031813A 2011-06-29 2012-06-28 composição para aplicação tópica BR112013031813A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161502725P 2011-06-29 2011-06-29
PCT/IL2012/050223 WO2013001536A1 (en) 2011-06-29 2012-06-28 Stabilized topical formulations containing core-shell microcapsules

Publications (1)

Publication Number Publication Date
BR112013031813A2 true BR112013031813A2 (pt) 2016-12-13

Family

ID=47423504

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013031813A BR112013031813A2 (pt) 2011-06-29 2012-06-28 composição para aplicação tópica

Country Status (13)

Country Link
US (1) US12053546B2 (pt)
EP (2) EP3698778B1 (pt)
JP (1) JP6033859B2 (pt)
KR (1) KR20140043397A (pt)
CN (2) CN103732217A (pt)
AU (1) AU2012277322A1 (pt)
BR (1) BR112013031813A2 (pt)
CA (1) CA2834681C (pt)
EA (1) EA201490178A1 (pt)
ES (2) ES2902498T3 (pt)
IL (1) IL229083A0 (pt)
MX (1) MX363379B (pt)
WO (1) WO2013001536A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5164840B2 (ja) 2005-08-02 2013-03-21 ソル − ゲル テクノロジーズ リミテッド 水不溶性成分の金属酸化物被覆
JP2011529392A (ja) 2008-07-31 2011-12-08 ゾル−ゲル テクノロジー リミテッド 活性成分および金属酸化物シェルを含むマイクロカプセル、その製造方法およびその使用
US11071878B2 (en) 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
EP3698778B1 (en) 2011-06-29 2021-10-13 Sol-Gel Technologies Ltd. Stabilized topical formulations containing core-shell microcapsules
US9687465B2 (en) * 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
EP3078415B1 (en) * 2013-12-06 2019-11-06 Kao Corporation Method for manufacturing microcapsules
WO2015092602A1 (en) * 2013-12-17 2015-06-25 Ranbaxy Laboratories Limited Topical pharmaceutical composition of a retinoid
GB201411704D0 (en) * 2014-07-01 2014-08-13 Lucideon Ltd Coated particles
WO2017029665A1 (en) 2015-08-20 2017-02-23 Sol-Gel Technologies Ltd. Compositions for topical application comprising benzoyl peroxide and adapalene
JP6960937B2 (ja) 2016-03-08 2021-11-05 リビング プルーフ インコーポレイテッド 長期持続性化粧品組成物
CN107260586B (zh) * 2017-06-27 2020-08-04 国珍健康科技(北京)有限公司 一种卸妆乳凝胶及其制备方法
CA3069287C (en) 2017-07-12 2022-08-30 Sol-Gel Technologies Ltd. Methods and compositions for the treatment of acne
JP2020527140A (ja) * 2017-07-12 2020-09-03 ソル − ゲル テクノロジーズ リミテッド カプセル化トレチノインを含む組成物
JP7244495B2 (ja) 2017-09-13 2023-03-22 リビング プルーフ インコーポレイテッド 長期持続性の化粧品組成物
WO2019055445A2 (en) 2017-09-13 2019-03-21 Living Proof, Inc. COLOR PROTECTION COMPOSITIONS
CA3084488A1 (en) 2017-11-20 2019-05-23 Living Proof, Inc. Properties for achieving long-lasting cosmetic performance
US11364198B2 (en) 2018-04-05 2022-06-21 Bausch Health Ireland Limited Polymeric emulsion delivery systems
JP2021522260A (ja) 2018-04-27 2021-08-30 リビング プルーフ インコーポレイテッド 長持ちする化粧用組成物
US10945987B2 (en) * 2019-02-19 2021-03-16 Sol-Gel Technologies Ltd. Method for providing early onset of action in the treatment of rosacea
KR20230027073A (ko) * 2020-05-22 2023-02-27 솔-겔 테크놀로지스 리미티드 안정화된 마이크로캡슐, 그의 제조 방법 및 그의 용도
KR102220752B1 (ko) * 2020-08-13 2021-03-02 한국콜마주식회사 캡슐을 함유하는 화장료 조성물
CN116919939A (zh) * 2022-04-02 2023-10-24 南京毓浠医药技术有限公司 一种维a酸和过氧化苯甲酰组合物及其制备方法和用途

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906108A (en) * 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
GB9021061D0 (en) 1990-09-27 1990-11-07 Unilever Plc Encapsulating method and products containing encapsulated material
WO1994018940A1 (en) * 1993-02-26 1994-09-01 Estee Lauder, Inc. Titanium dioxide dispersions, cosmetic compositions and methods for using the same
RU2134101C1 (ru) 1993-07-01 1999-08-10 Яманаухи Эуропе Б.В. Стабильные местнодействующие ретиноидные композиции
US5401517A (en) * 1993-11-15 1995-03-28 Elizabeth Arden Company, Division Of Conopco, Inc. Cosmetic method for treatment of skin
US5720949A (en) * 1996-05-06 1998-02-24 Bristol-Myers Squibb Company Foamable cosmetic mask product
US5891476A (en) 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
ES2216360T3 (es) 1998-02-06 2004-10-16 Seiwa Kasei Co., Ltd. Microcapsula con pared particular y su procedimiento de fabricacion.
US6099894A (en) 1998-07-27 2000-08-08 Frisby Technologies, Inc. Gel-coated microcapsules
EP1104287B9 (en) 1998-08-13 2012-12-19 Sol-Gel Technologies Ltd. Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof
US6238650B1 (en) * 1999-05-26 2001-05-29 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
US6468509B2 (en) 1998-12-18 2002-10-22 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
AU4775400A (en) 1999-05-25 2000-12-12 Sol-Gel Technologies Ltd. A method for obtaining photostable sunscreen compositions
JP4979109B2 (ja) 2000-04-21 2012-07-18 ゾル−ゲル テクノロジーズ リミテッド 局所的有効成分の増強された配合安定性および送達を示す組成物
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
US6979440B2 (en) * 2001-01-29 2005-12-27 Salvona, Llc Compositions and method for targeted controlled delivery of active ingredients and sensory markers onto hair, skin, and fabric
DE10117842A1 (de) * 2001-04-04 2002-10-17 Coty Bv Kosmetische Vitamin-A-haltige Zubereitung
GB0119831D0 (en) 2001-08-14 2001-10-10 Unilever Plc Dual compartment packaged cosmetic composition
US6913825B2 (en) 2001-09-20 2005-07-05 University Of Notre Dame Du Lac Process for making mesoporous silicate nanoparticle coatings and hollow mesoporous silica nano-shells
US20030082217A1 (en) * 2001-10-25 2003-05-01 Isabelle Afriat Use of heat-stabilizing microcapsules to improve the activity or penetration of cosmetic or pharmaceutical active principles
US7923030B2 (en) * 2003-03-14 2011-04-12 Sol-Gel Technologies, Inc. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
US20040202726A1 (en) * 2003-04-10 2004-10-14 Deshay Samuel L. Topical blood pressure composition
CA2533406C (en) 2003-07-31 2013-01-22 Sol-Gel Technologies Ltd. Microcapsules loaded with active ingredients and a method for their preparation
JP2007531777A (ja) 2004-04-05 2007-11-08 コグニス・アイピー・マネージメント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 部分グリセリドとペンタエリスリトールエステルに基づくワックス混合物
DE102004017221A1 (de) 2004-04-05 2005-10-20 Cognis Ip Man Gmbh O/W-Gel-Zusammensetzungen mit Estern des Pentaerythrits oder dessen Oligomeren
US20060014834A1 (en) 2004-05-11 2006-01-19 Mohan Vishnupad Retinoid solutions and formulations made therefrom
JP5164840B2 (ja) 2005-08-02 2013-03-21 ソル − ゲル テクノロジーズ リミテッド 水不溶性成分の金属酸化物被覆
WO2007092312A2 (en) * 2006-02-03 2007-08-16 Stiefel Laboratories, Inc. Topical skin treating compositions
EP2007210A4 (en) 2006-02-10 2011-07-06 Dupont Tate & Lyle Bio Products Company Llc COMPOSITIONS WITH MONO AND DIESELS FROM 1,3-PROPANEL ON BIOLOGICAL BASIS
AU2007273935B2 (en) 2006-03-31 2011-08-18 Stiefel Research Australia Pty Ltd Foamable suspension gel
US10525433B2 (en) 2006-12-12 2020-01-07 Sol-Gel Technologies Ltd. Formation of nanometric core-shell particles having a metal oxide shell
EA200970724A1 (ru) 2007-02-01 2010-02-26 Сол-Джел Текнолоджиз Лтд. Композиции для местного применения, содержащие пероксид и ретиноид
CA2677185C (en) 2007-02-01 2013-12-03 Ofer Toledano Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
KR100837558B1 (ko) 2007-04-30 2008-06-12 (주)아모레퍼시픽 이중으로 안정된 세라마이드 나노 캡슐 포함 에멀젼조성물, 그의 제조방법 및 이를 이용한 피부 화장료 조성물
WO2008134908A1 (en) 2007-05-08 2008-11-13 Givaudan Sa Wax encapsulation
WO2009051839A1 (en) 2007-10-18 2009-04-23 Medicis Pharmaceutical Corporation Aqueous retinoid and benzoyl peroxide gel
US20090130220A1 (en) * 2007-11-20 2009-05-21 Johnson Pamela A Cosmetic composition having pomace olive oil
JP5622582B2 (ja) * 2007-11-30 2014-11-12 ガルデルマ・リサーチ・アンド・デヴェロップメント 少なくとも1種のナフトエ酸誘導体、過酸化ベンゾイルおよび少なくとも1種の皮膜形成剤を含む組成物、その調製方法、およびその使用
US9870123B1 (en) 2008-04-18 2018-01-16 Universal Electronics Inc. Selecting a picture of a device to identify an associated codeset
US20100029765A1 (en) 2008-07-30 2010-02-04 Ranbaxy Labortories Limited Topical aqueous composition comprising tretinoin
JP2011529392A (ja) 2008-07-31 2011-12-08 ゾル−ゲル テクノロジー リミテッド 活性成分および金属酸化物シェルを含むマイクロカプセル、その製造方法およびその使用
US10653899B2 (en) 2009-12-31 2020-05-19 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US11071878B2 (en) 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US10512796B2 (en) 2009-12-31 2019-12-24 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
EP3698778B1 (en) 2011-06-29 2021-10-13 Sol-Gel Technologies Ltd. Stabilized topical formulations containing core-shell microcapsules

Also Published As

Publication number Publication date
CN107625743B (zh) 2021-08-27
EP2726067A4 (en) 2014-12-24
MX363379B (es) 2019-03-21
CN103732217A (zh) 2014-04-16
CA2834681A1 (en) 2013-01-03
WO2013001536A1 (en) 2013-01-03
IL229083A0 (en) 2013-12-31
MX2013013722A (es) 2014-02-27
KR20140043397A (ko) 2014-04-09
CN107625743A (zh) 2018-01-26
ES2786103T3 (es) 2020-10-08
ES2902498T3 (es) 2022-03-28
EP3698778B1 (en) 2021-10-13
US20130095185A1 (en) 2013-04-18
EP2726067A1 (en) 2014-05-07
EA201490178A1 (ru) 2014-04-30
EP2726067B1 (en) 2020-02-19
AU2012277322A1 (en) 2013-11-14
EP3698778A1 (en) 2020-08-26
JP6033859B2 (ja) 2016-11-30
JP2014518259A (ja) 2014-07-28
US12053546B2 (en) 2024-08-06
CA2834681C (en) 2019-03-12

Similar Documents

Publication Publication Date Title
BR112013031813A2 (pt) composição para aplicação tópica
SMT201600308B (it) Composti di benzene arile-o eteroarile-sostituiti
CR20130677A (es) FORMULACIÓN PARA ANTICUERPO ANTI-a4ß7
BR112013022112A2 (pt) composição
BR112013022102A2 (pt) composição
DK2686017T3 (da) Oftalmisk sammensætning
CO6801648A2 (es) Formulación para anticuerpo anti-α4β7
BR112014004395A2 (pt) composição
DK2694038T3 (da) Farmaceutisk sammensætning
BRDI7106210S (pt) Configuração aplicada para lâmina para microscópio
BR302012002270S1 (pt) Configuracao aplicada em motoneta
DK2730310T3 (da) Applikator
BR112013033808A2 (pt) composição
BR112014013682A2 (pt) composição para cuidado pessoal
BR112014009963A2 (pt) composição dietética
PT2694021E (pt) Composição cicatrizante para aplicação tópica
BR112014007030A2 (pt) composição
BR112014032712A2 (pt) composição
BR112013031544A2 (pt) composição tópica.
BR112014011723A2 (pt) composição antiperspirante
BR112013031220A2 (pt) composição tópica
BR112014013684A2 (pt) composição para cuidado pessoal
BR112013022907A2 (pt) composição farmacêutica
SMT201600068B (it) Composizione dolcificante
DK2726579T3 (da) Sammensætning

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]